pyridine has been researched along with indene in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bouska, J; Bui, MH; Chen, Z; Claiborne, A; Kovar, P; Li, G; Lin, NH; Merta, PJ; Olson, A; Osterling, D; Park, C; Przytulinska, M; Rosenberg, SH; Sham, HL; Sowin, TJ; Stewart, KD; Tao, ZF; Tong, Y; Zhang, H | 1 |
| Hwang, SY; Katila, P; Kunwar, S; Kwon, Y; Lee, ES; Man Kadayat, T; Seo, M | 1 |
2 other study(ies) available for pyridine and indene
| Article | Year |
|---|---|
Cyanopyridyl containing 1,4-dihydroindeno[1,2-c]pyrazoles as potent checkpoint kinase 1 inhibitors: improving oral biovailability.
Topics: Administration, Oral; Animals; Checkpoint Kinase 1; Cyanides; Hydrogen; Indenes; Inhibitory Concentration 50; Mice; Molecular Structure; Protein Kinase Inhibitors; Protein Kinases; Pyrazoles; Pyridines; Rats; Structure-Activity Relationship | 2007 |
4-Flourophenyl-substituted 5H-indeno[1,2-b]pyridinols with enhanced topoisomerase IIα inhibitory activity: Synthesis, biological evaluation, and structure-activity relationships.
Topics: Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; DNA Topoisomerases, Type II; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Humans; Indenes; Molecular Structure; Poly-ADP-Ribose Binding Proteins; Pyridines; Structure-Activity Relationship; Topoisomerase II Inhibitors | 2021 |